Medtronic PLC Total Liabilities
Medtronic PLC total liabilities. Based on the latest financial reports, Medtronic PLC (MDT) has total liabilities worth $42.96 Billion USD as of April 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MDT financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Medtronic PLC (1986–2026)
Total liabilities of Medtronic PLC from 1986 to 2026. This chart illustrates how Medtronic PLC's total liabilities have evolved over time, based on quarterly financial data. Explore Medtronic PLC (MDT) investment intensity to see how much of total assets are deployed in long-term investments.
Medtronic PLC Competitors by Total Liabilities
The table below lists competitors of Medtronic PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GlaxoSmithKline plc
MX:GSKN
|
Mexico | MX$45.59 Billion |
|
Rio Tinto Group
F:RIOA
|
Germany | €61.08 Billion |
|
FAST RETAIL. CO. ADR 1/10
F:FR70
|
Germany | €1.59 Trillion |
|
DBS GROUP ADR/4 SD 1
F:DEV
|
Germany | €895.38 Billion |
|
Canadian Imperial Bank Of Commerce
TO:CM
|
Canada | CA$1.09 Trillion |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
USA | $57.16 Billion |
|
Accenture plc
NYSE:ACN
|
USA | $35.79 Billion |
|
Enbridge Inc
TO:ENB
|
Canada | CA$162.80 Billion |
Liability Composition Analysis (1986–2026)
This chart breaks down Medtronic PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Medtronic PLC.
Liquidity & Leverage Metrics
Medtronic PLC Total Liabilities Ratios Explained
Medtronic PLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medtronic PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medtronic PLC (1986–2026)
The table below shows the annual total liabilities of Medtronic PLC from 1986 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-04-30 | $42.96 Billion | -1.08% |
| 2025-04-30 | $43.42 Billion | +9.76% |
| 2024-04-30 | $39.56 Billion | +0.71% |
| 2023-04-30 | $39.28 Billion | +2.68% |
| 2022-04-30 | $38.26 Billion | -7.77% |
| 2021-04-30 | $41.48 Billion | +4.18% |
| 2020-04-30 | $39.82 Billion | +0.85% |
| 2019-04-30 | $39.48 Billion | -2.68% |
| 2018-04-30 | $40.57 Billion | -17.87% |
| 2017-04-30 | $49.40 Billion | +3.52% |
| 2016-04-30 | $47.72 Billion | -10.73% |
| 2015-04-30 | $53.45 Billion | +188.95% |
| 2014-04-30 | $18.50 Billion | +14.74% |
| 2013-04-30 | $16.12 Billion | +0.96% |
| 2012-04-30 | $15.97 Billion | +10.47% |
| 2011-04-30 | $14.46 Billion | +7.39% |
| 2010-04-30 | $13.46 Billion | +24.52% |
| 2009-04-30 | $10.81 Billion | +1.39% |
| 2008-04-30 | $10.66 Billion | +24.92% |
| 2007-04-30 | $8.54 Billion | -16.99% |
| 2006-04-30 | $10.28 Billion | +66.71% |
| 2005-04-30 | $6.17 Billion | +22.53% |
| 2004-04-30 | $5.03 Billion | +14.03% |
| 2003-04-30 | $4.41 Billion | -1.32% |
| 2002-04-30 | $4.47 Billion | +192.49% |
| 2001-04-30 | $1.53 Billion | +29.84% |
| 2000-04-30 | $1.18 Billion | -3.11% |
| 1999-04-30 | $1.22 Billion | +66.42% |
| 1998-04-30 | $730.50 Million | +10.18% |
| 1997-04-30 | $663.00 Million | -7.14% |
| 1996-04-30 | $714.00 Million | +16.72% |
| 1995-04-30 | $611.70 Million | +7.35% |
| 1994-04-30 | $569.80 Million | +28.04% |
| 1993-04-30 | $445.00 Million | +21.25% |
| 1992-04-30 | $367.00 Million | +7.66% |
| 1991-04-30 | $340.90 Million | +8.05% |
| 1990-04-30 | $315.50 Million | +10.31% |
| 1989-04-30 | $286.00 Million | +16.78% |
| 1988-04-30 | $244.90 Million | +41.81% |
| 1987-04-30 | $172.70 Million | -3.36% |
| 1986-04-30 | $178.70 Million | -- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardiovert… Read more